Search
for
Sort by
Research 121–150 of 1000+
- Two siblings with vitamin-D-dependent rickets type II: No recurrence of rickets for 14 years after cessation of therapy
- A Unique Expression of Keratin 14 in a Subset of Trophoblast Cells
- Prevalence of androgenic alopecia in 14- to 18-year-old female high school students in Shiraz
- 1. 2年間の低負荷レジスタンストレーニングが高齢者の筋機能に及ぼす効果(第134回日本体力医学会関東地方会)
- Dengue-associated telogen effluvium: A report of 14 patients
- The Prevalence of Polycystic Ovarian Syndrome in 14-18 year old girls of Zanjan High Schools, 2008
- Examination of Clinical and Demographic Characteristics of 14 Cases with Frontal Fibrosing Alopecia
- Homoeopathic management of alopecia areata in a 14-year-old male: A case report
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
- Synthesis, Anticancer and Molecular Docking Studies of 2-(4-chlorophenyl)-5-aryl-1,3,4-Oxadiazole Analogues
- Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran
- Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021
- SF-066-4 線維芽細胞+血管内皮前駆細胞共培養シートを用いた新たな膵断端処理法の開発(膵-2,サージカルフォーラム,第110回日本外科学会定期学術集会)
- First drug for severe alopecia recommended by NICE could benefit 14,000 patients
- Review of the ABCRC Controversies Workshop May 13-14, 2016 • Fortaleza, Brazil
- Small cell lung cancer: Results of a phase II study of 1,2,4 triglycidylurazol
- 874 Mesothelioma of the Tunica Vaginalis Testis: A Clinicopathologic Study of 14 Patients with Evaluation of Markers of Mesothelial Malignancy
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients
- Autologous Platelet Rich Plasma as a Treatment of Male Androgenetic Alopecia: Study of 14 Cases
- Limberg Transposition Flap in Treatment of Sacro-coccygeal Pilonidal Sinus: A series of 14 Cases
- ASSISTÊNCIA DE ENFERMAGEM AO HPV: TRATAMENTO E PREVENÇÃO EM ADOLESCENTE DE 9 A 14 ANOS DE IDADE
- Comparison of Levels of Androgenic Hormones in various Phenotypes of Polycystic Ovarian Syndrome in High School Girls aging 14 to 18 Years
- Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): Three- and 4-year results
- Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (Setipiprant/ACT-129968)
- Discovery of (2<i>S</i>)-<i>N</i>-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment
- Book Review: “Integrated Procedures in Facial Cosmetic Surgery” ISBN 978-3-030-46992-4 ISBN 978-3-030-46993-1 (eBook) © Springer Nature Switzerland AG 2021
- Pengaruh Minat dan Kesiapan Belajar Siswa Terhadap Prestasi Belajar Mata Pelajaran Gambar Bangunan Gedung 1 Kelas XI Tahun Ajaran 2011/2012 SMK Negeri 4 Semarang
- Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss (version 1; referees: 4 approved)
- BindingDB Entry 50021519: Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment.